Showing results (1-10 of 695) with videos related to
Sort By:
Pageof 70
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
New cancer therapy using genetically-engineered oncolytic Sendai virus vectorHiroaki Kinoh, Makoto InoueClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated ratsYasuo Iwadate, Makoto Inoue, Takashi Saegusa, et al.Accounts of Chemical Research|November 9, 2020
Tumor-Targeted Nanomedicine for ImmunotherapyHoracio Cabral, Hiroaki Kinoh, Kazunori KataokaRoux'S Archives of Developmental Biology : the Official Organ of the EDBO|March 18, 2017
Seasonal variations in the production of the egg-jelly macromolecule, a fucose sulphate glycoconjugate, by the accessory cells in the ovary of the sea urchin Hemicentrotus pulcherrimusHiroyuki Abe, Hiroaki Kinoh, Norio SuzukiDevelopment, Growth & Differentiation|June 7, 2023
Purification and Characterization of the Egg Jelly Macromolecules, Sialoglycoprotein and Fucose Sulfate Glycoconjugate, of the Sea Urchin Hemicentrotus Pulcherrimus: (sialoglycoprotein/fucose sulfate glycoconjugate/acrosome reaction/egg jelly/sea urchin spermatozoa)Takeshi Shimizu, Hiroaki Kinoh, Masaaki Yamaguchi, et al.Roux'S Archives of Developmental Biology : the Official Organ of the EDBO|March 18, 2017
The egg-jelly macromolecule, a fucose sulphate glycoconjugate, originates from the accessory cells of the ovary in the sea urchin Hemicentrotus pulcherrimusHiroyuki Abe, Hiroaki Kinoh, Taneaki Oikawa, et al.Roux'S Archives of Developmental Biology : the Official Organ of the EDBO|March 18, 2017
Expression of a putative precursor mRNA for sperm-activating peptide I in accessory cells of the ovary in the sea urchin Hemicentrotus pulcherrimusHiroaki Kinoh, Takeshi Shimizu, Hirotaka Fujimoto, et al.Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimenYoshikazu Yonemitsu, Yasuji Ueda, Hiroaki Kinoh, et al.Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimenYoshikazu Yonemitsu, Yasuji Ueda, Hiroaki Kinoh, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virusAtsushi Komaru, Yasuji Ueda, Aki Furuya, et al.Pageof 70